Jump to content
Sign in to follow this  

FDA ends emergency authorization for hydroxychloroquine

Recommended Posts


The Food and Drug Administration is withdrawing emergency authorization for chloroquine and hydroxychloroquine as treatments for COVID-19, the agency announced today. Recent clinical trials showed that the drugs were not effective against the disease.

The medications are still FDA-approved for diseases like malaria and lupus, so they remain on the market. Because they are approved for other diseases, doctors could technically still prescribe them for COVID-19 patients under off-label use. Clinical trials focusing on the drugs can also continue. This decision, though, indicates that the FDA is no longer confident that the drug would benefit COVID-19 patients.

“We now believe that the suggested dosing regimens for [chloroquine] and...

Continue reading…

View the full article

Share this post

Link to post
Share on other sites

Join the conversation

You can post now and register later. If you have an account, sign in now to post with your account.

Reply to this topic...

×   Pasted as rich text.   Paste as plain text instead

  Only 75 emoji are allowed.

×   Your link has been automatically embedded.   Display as a link instead

×   Your previous content has been restored.   Clear editor

×   You cannot paste images directly. Upload or insert images from URL.

Sign in to follow this  

  • Recently Browsing   0 members

    No registered users viewing this page.

  • Create New...

Important Information

By using The Great Escaped Online Community, you agree to our Privacy Policy and Terms of Use